R. Cheingsong‐Popov

Author

R. Cheingsong‐Popov

Also Known As

R Cheingsong-Popov, R Cheĭngsong-Popov, R. CHEINGSONG-POPOV, R. CHEINGSONG‐POPOV, R. Cheingsong-Popov, R. Cheingsong‐Popov, RACHANEE CHEINGSONG-POPOV, Rachanee Cheingsong-Popov

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research Middlesex Hospital St Mary's Hospital St. Mary's Hospital St. Stephen’s Hospital

About

R. Cheingsong‐Popov is an author at Institute of Cancer Research specializing in medicine, virology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	17	1.5K
2	Public Health	4	4	257
3	Social Sciences	3	3	158
4	Cell Biology	2	2	179
5	Allergy	1	1	48

R. Cheingsong‐Popov

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
PREVALENCE OF ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE III IN AIDS AND AIDS-RISK PATIENTS IN BRITAIN R. Cheingsong‐Popov, Richard Weiss, Angus Dalgleish, The Lancet Primary ImmunodeficiencyHuman RetrovirusImmunologyAntiviral ResponseVirology	1984	228
Productive Infection and Cell-Free Transmission of Human T-Cell Leukemia Virus in a Nonlymphoid Cell Line Paul R. Clapham, K. Nagy, R. Cheingsong‐Popov, Science Nonlymphoid Cell LineProductive InfectionViral ReplicationHuman RetrovirusHos/pl Cells	1983	210
HUMAN T-LYMPHOTROPIC VIRUS TYPE III (HTLV-III) INFECTION IN SERONEGATIVE HAEMOPHILIACS AFTER TRANSFUSION OF FACTOR VIII C A Ludlam, C. M. Steel, R. Cheingsong‐Popov, The Lancet PathogenesisHematologyImmunologyPathologyVirology	1985	140
LOW PREVALENCE IN THE UK OF HTLV-I AND HTLV-II INFECTION IN SUBJECTS WITH AIDS, WITH EXTENDED LYMPHADENOPATHY, AND AT RISK OF AIDS Richard S. Tedder, D.C. Shanson, D J Jeffries, The Lancet Primary ImmunodeficiencyViral PersistenceWith Extended LymphadenopathyHuman RetrovirusClinical Epidemiology	1984	122
Serotyping of HIV Type 1 Infections: Definition, Relationship to Viral Genetic Subtypes, and Assay Evaluation R. Cheingsong‐Popov, Saladin Osmanov, Chou‐Pong Pau, AIDS Research and Human Retroviruses	1998	103
HTLV-III SEROLOGY DISTINGUISHES ATYPICAL AND ENDEMIC KAPOSI'S SARCOMA IN AFRICA Anne Bayley, R. Cheingsong‐Popov, Angus Dalgleish, The Lancet MedicineSarcoma In AfricaPathologyVirology	1985	103
Serotyping HIV Type 1 by Antibody Binding to the V3 Loop: Relationship to Viral Genotype R. Cheingsong‐Popov, Simon Lister, David Callow, AIDS Research and Human Retroviruses Antibody BindingSynthetic V3 PeptidesImmunologyViral GenotypeViral Structural Protein	1994	102
Proposed molecular basis of murine tumor cell-hepatocyte interaction. Georg F. Springer, R. Cheingsong‐Popov, Volker Schirrmacher, Journal of Biological Chemistry Tumor BiologyHepatologySodium HomeostasisBuffered SalineLiver Physiology	1983	97
Hepatocyte-tumor cell interaction in vitro. I. Conditions for rosette formation and inhibition by anti-H-2 antibody. Volker Schirrmacher, R. Cheingsong‐Popov, Heinz Arnheiter The Journal of Experimental Medicine ImmunologyMurine HepatocytesTumor BiologyHepatobiliary TumorTumor Immunity	1980	82
Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection. R. Cheingsong‐Popov, C Panagiotidi, Stella Bowcock, BMJ	1991	78

Page 1